2010
DOI: 10.1107/s1600536810049779
|View full text |Cite
|
Sign up to set email alerts
|

Poly[[μ2-aqua-tetraaquadi-μ3-malonato-nickel(II)strontium(II)] dihydrate]

Abstract: Key indicators: single-crystal X-ray study; T = 294 K; mean (C-C) = 0.006 Å; R factor = 0.035; wR factor = 0.098; data-to-parameter ratio = 12.5.The unit-cell parameters for the title mixed-metal coordination polymer, {[NiSr(C 3 H 2 O 4 ) 2 (H 2 O) 5 ]Á2H 2 O} n , which is isostructural with its Co-containing analogue, were reported previously [Gil de Muro et al. (1999). Eur. J. Inorg. Chem. pp. 935-943]; the full crystal structure including a description of the hydrogen bonding is reported here. The Sr 2+ ion… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Because of the systemic nature of osteoporosis it is not possible that local acting biomaterials themselves influence the illness but modifying them with drugs, growth factors, organic and inorganic active components might promise success. Recently it has been described that strontium administration was successful for the treatment of osteoporosis [2], [3]. Thus one animal subgroup received an implant with a strontium modification of the CPC.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Because of the systemic nature of osteoporosis it is not possible that local acting biomaterials themselves influence the illness but modifying them with drugs, growth factors, organic and inorganic active components might promise success. Recently it has been described that strontium administration was successful for the treatment of osteoporosis [2], [3]. Thus one animal subgroup received an implant with a strontium modification of the CPC.…”
Section: Discussionmentioning
confidence: 99%
“…The commercially available bone substitution materials are not etiology-adapted and therefore not appropriate for the application in osteoporotic damaged bone. In the last years it has been worked out that modification with strontium [2], [3], bisphosphonate [4] as well as enhanced resorption capacity and changes from solid material to interconnected porous material [5] improves the materials. High resorption capacity goes along with the disposal of the degraded fragments often inserted in cell organelles of macrophages.…”
Section: Introductionmentioning
confidence: 99%